Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

Caitlin E. Cox

January 23, 2026

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Caitlin E. Cox

September 18, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Daily News

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

Yael L. Maxwell

December 16, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Conference News ACC 2021

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Caitlin E. Cox

May 25, 2021

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Caitlin E. Cox

June 03, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Caitlin E. Cox

January 03, 2020

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Daily News

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Caitlin E. Cox

July 25, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

Advertisement

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content